Tan, Zhiyuan
Völler, Swantje
Yin, Anyue
Rieborn, Amy
Gelderblom, Hans
van der Hulle, Tom
Knibbe, Catherijne A. J.
Moes, Dirk Jan A. R. https://orcid.org/0000-0003-3219-253X
Article History
Accepted: 24 March 2025
First Online: 22 April 2025
Declarations
:
: The work of Zhiyuan Tan was supported by the China Scholarship Council (202108310028).
: Catherijne A.J. Knibbe and Dirk Jan A.R. Moes are Editorial Board members of Clinical Pharmacokinetics. Catherijne A.J. Knibbe and Dirk Jan A.R. Moes were not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions.
: Data are available from the corresponding author upon reasonable request. All the model codes were provided in supplementary materials.
: This study was conducted in accordance with Good Clinical Practice guidelines and the Declaration of Helsinki. The protocol was approved by the institutional review board (IRB) at the Scientific Committee of the Department of Medical Oncology, Medical Ethics Review Committee Leiden/Den Haag/Delft. As retrospective data from routine clinical care were used, a waiver was granted for the requirement of informed consent by the IRB.
: As retrospective data from routine clinical care were used, a waiver was granted for the requirement of informed consent by the IRB.
: Z.T., S.V., A.Y., C.A.J.K., and D.J.A.R.M. contributed to the research design, performed research, analyzed data, and wrote the manuscript. A.R., A.J.G., and T.H. treated patients and reviewed and revised the manuscript.